GL1X · GenesisL1 explorer

MolNFT v1 · #378415 · protein

AlphaFold monomer V2.0 prediction for dual-specificity RNA methyltransferase rlmn (B2SXT2)

B2SXT2: “AlphaFold monomer V2.0 prediction for dual-specificity RNA methyltransferase rlmn (B2SXT2)”. 3 pockets (best druggability 0.83). MolNFT v1 #378415 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

Accession
B2SXT2
Type
protein
Length
383 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x9188600a0FCa2914254C94299b1bd9721Bc4D500
Molecule
Dual-specificity RNA methyltransferase rlmn
UniProt
B2SXT2
Pockets
3 · best druggability 0.83

Structure

1 distinct chain · 36% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADual-specificity RNA methyltransferase rlmnprotein38336% helix, 19% strandB2SXT2

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11950.830.9730empty
22970.670.8236empty
3590.380.7917empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.